Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care
{{output}}
Aims: To assess adherence and persistence to sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP1-RA), and dipeptidyl peptidase-4 inhibitors (DPP4i) in routine care. ... ...
